COMPARATIVE STUDY OF DOWNSTA6IN6/PAP SMEAR/COLPOSCOPY/COLPOSCOPIC BIOPSY IN THE DETECTION OF CERVICAL PATHOLOGY

Main Article Content

R. NITHYA
R. SINDHU BHAIRAVI

Abstract

Background: Cancer cervix continues to be the most common genital cancer accounting for 80% of female genital cancer. It is the leading cause for mortality & morbidity among women worldwide.

Materials and Methods: This study was a prospective study conducted in the Department of Obstetrics and Gynecology during the period of July 2010 to Sep 2011 in 250 women who fulfilled the inclusion criteria. 5.5% of the study group belonged to other religions. Cytology, Colposcopy and HPE showed more abnormalities in Hindus. 2

Results: 4.2% of Hindus showed dysplasia on HPE.  Among the para 1 to 2, 17.5% had dysplasia on HPE, among the para 3 to 4, 22.2% had dysplasia on HPE and among the para 5 and above, 46.2% had dysplasia· on HPE showing high incidence of dysplasia in the multiparty. The incidence of dysplasia was found to be high among the lower socio-economic groups.(5.9% of class III,25% of class IV and 29.8% of class V had dysplasia on HPE. 33.9% of women who got married at less than 19 years and 10.4% of women married between 20-29 years had dysplasia on HPE showing the high incidence of dysplasia in women with early coitarche. 68.2% of the patients had leucorrhoea as presenting symptoms, of which 22.7% had dysplasia on HPE,1.3% had malignancy on biopsy.2.7% of the patients had postictal bleeding, of which 33.3% had dysplasia on HPE and 33.3% had malignancy on HPE indicating the high incidence of dysplasia in patients with Postictal bleeding and leucorrhoea.

Conclusion: Downsta6in6/Pap Smear is an easy and perspective method and its importance lies in teaching, diagnosis and management of cervical lesions, neoplastic and non- neoplastic.

Keywords:
Immunodeficiency, colposcopy, cervical cancer, pathology, sensitivity, specificity

Article Details

How to Cite
NITHYA, R., & BHAIRAVI, R. S. (2021). COMPARATIVE STUDY OF DOWNSTA6IN6/PAP SMEAR/COLPOSCOPY/COLPOSCOPIC BIOPSY IN THE DETECTION OF CERVICAL PATHOLOGY. UTTAR PRADESH JOURNAL OF ZOOLOGY, 42(24), 180-192. Retrieved from http://mbimph.com/index.php/UPJOZ/article/view/2678
Section
Original Research Article

References

Miller AB. Cervical cancer screen mg program managerial guidelines WHO Geneva. 1992; 6(14): 44-8.

Jemel A, Thomas A, Murray T, et al. Cancer statistics 2002, CA cancer J. Clin. 2002;52:23-47.

Pandey K, Bhagoliwal A. Cancer Cervix - need for mass surveillance program specially in rural areas. The Jr of Obst & Gynec India. 2005;55(5):436-9.

Parkin DM, Bray F, Ferlay J et al. Estimating the world Cancer burden: Globocan 2000 Int Jr Cancer. 2£Ql; 94:153-6.

Bharani B, Phatak SR. Acetic acid visualization of the cervix-an alternative to colposcopy in evaluation of cervix at risk. Jr. Obst & Gynec India. 2005;55(6):530-33.

Shalini. R, Arnita. S, Neera. M.A, How alarming is post coital bleeding - a cytologic, colposcopic and histological evaluation Gynaecol Obstet Invest. 1998, 45(3): 205-8.

Vaidya A, Comparison of pap test among high risk and non risk female, Kathmandu University, Medic ! Journal. 2003;1(1):8-13.

Adadevoh SW, Forkouh BK. Cervical cancer screening. International Journal of Gynaecology and Obstetrics. 1993 Oct;43 (1): 63-4.

Kushtagi P, Fernandez P. Significance of persistent inflammatory, cervical smears in sexually active women of reproductive age. The Journal of Obs and Gyn. of India. 2002;Jan – Feb:52(1):124 -6.

S Ambika, Y Manojkumar, S Arunachalam, B Gowdhami, K Meenakshi Sundaram, Biomolecular interaction, anti-cancer and anti-angiogenic properties of cobalt (III) Schiff base complexes

Scientific reports. 2019; Feb 25;9(1):2721.